The Mautner Project, the D.C.-based national lesbian health organization, is celebrating its 20th anniversary Saturday with 800 people gathered for a gala fundraising dinner and dance party at the Omni Shoreham Hotel.
The group’s founder, Susan Hester, and its executive director, Leslie Calman, say the festive occasion marks the success of an organization that bears the name of a woman whose forward-thinking ideas and untimely death in 1989 became the inspiration for its mission and programs.
“Before she died of cancer at the age of 44, Mary-Helen Mautner asked her partner Susan Hester to create an organization to help other lesbians and their loved ones meet the challenges of life-threatening illnesses,” says the group’s web site. “Susan promised to make Mary-Helen’s dream a reality — and the Mautner Project is a result of that promise.”
With Hester serving as executive director for the first six years, Mautner Project embarked on a mission to fulfill a vision that Hester says her partner sketched out on a single piece of paper while in the hospital shortly before her death.
“She told me that during a bone scan she realized how many lesbians in her situation would not have someone with them,” Hester recalled in a 2008 essay. “They would be going through this all alone. And she had an idea of how to deal with that.”
Before becoming ill, Mautner was an attorney with the U.S. Department of Labor and a keen observer of the LGBT rights and AIDS advocacy movements, including programs by AIDS groups to assign volunteer “buddies” to assist gay men with AIDS-related illnesses, Hester said.
“She wanted an organization that would provide support for lesbians who didn’t have the support she had,” Hester said.
Calman, who began her tenure as executive director two years ago, said the early vision of both Mary-Helen Mautner and Hester evolved into a nationally acclaimed health services and advocacy organization that, among other things, educates health care professionals on the needs of lesbian, bisexual and transgender women.
The organization’s programs include providing direct services and support for lesbian, bisexual and transgender women with cancer and other life-threatening illnesses; and offering support groups for cancer clients, caregivers and others grieving over a loss. It also educates the lesbian, bi and trans communities about preventive health practices and nutrition and offers smoking cessation programs and programs to address obesity.
“The most remarkable thing to me about the Mautner Project is that lesbians came together — created a vibrant organization — and introduced the rest of the country, including health care providers and government policy makers, to the vision of a lesbian health agenda,” Hester told DC Agenda.
“But 20 years later — despite the remarkable exposure of lesbians and gays — there are still more lesbians and gay men who are not out to their health care providers than the number who live free and open lives,” she said. “There are more health care providers who blush or blanch at the idea of working with lesbians than there are who welcome us.”
Calman said Mautner Project currently has a staff of six full-time and two part-time employees and an annual budget of about $900,000. In keeping with its tradition of volunteer help, the group has 60 volunteers who help carry out its programs.
“We’re still small and scrappy,” she said.
Hester and Calman credited former executive director Kathleen DeBold, who headed the organization from 2000 to 2007, with expanding its budget and programs, transforming it from a local group to a national organization.
Last year, the group weighed in on a controversy over when women should begin undergoing mammogram tests for breast cancer. The controversy was triggered by a U.S. government medical task force, which issued recommendations suggesting that mammograms may not be beneficial for women between the ages of 40 and 50.
Among other things, the task force pointed to data showing there was a statistically insignificant difference in the lives saved of women who underwent mammograms in their 40s and those who did not. The task force concluded that the very small difference in the number of breast cancer cases detected in women taking the test in their 40s did not justify the expense, subsequent biopsies and “anxieties” the tests generated.
In an open letter to the community, Calman and D.C. physician Linda Spooner, chair of the Mautner Project’s board of directors, sided with the American Cancer Society, which urged women between 40 and 50 to ignore the task force recommendation and take yearly mammograms.
“Mammography is a diagnostic tool, not a cure, and we need a cure,” Spooner and Calman said in their letter. “But for the task of early and timely detection, mammograms, in conjunction with clinical breast exams, are our best tool.”
They added that the task force’s suggestion that avoiding mammograms would spare women anxiety “strikes us as patronizing and dangerous.”
Should we vacation in homophobic countries?
Secret gay bar in St. Petersburg seemed unfathomable
ST. PETERSBURG, Russia — The tiny rainbow light projecting onto the corner baseboard of the bar and tipsy people constantly belting out Mariah Carey karaoke songs clued me in. There was something unique happening here. It wasn’t until a gentleman with glittered cheeks approached me to say how fabulous my dress was that I suddenly clocked it. I’d unknowingly ended up in a gay bar in the middle of Saint Petersburg, Russia.
A flood of overwhelming joy first took over. Before coming to Russia on vacation, I knew all too well the discrimination and fear LGBTQ Russians lived in. A gay bar in Russia, even a secret one like this, seemed unfathomable, so being where people could unapologetically be out and proud — even if it was only in the compounds of these four walls — was emotionally profound.
But within seconds, dread took over. Were we all safe? If you didn’t know what to look out for, you’d assume this was just like every other neighboring non-gay bar — it wasn’t hidden or anything. I wondered what was stopping a homophobe, if they found out, from vandalizing the bar or doing something much worse.
After all, Russia approved a legislation in 2013 prohibiting the distribution of information about LGBTQ matters and relationships to minors. The legislation, known as the “gay propaganda law,” specifies that any act or event that authorities believe promotes homosexuality to individuals under the age of 18 is a punishable felony. According to a 2018 report by the international rights organization Human Rights Watch, anti-LGBTQ violence in the country spiked after it passed. The bill perpetuates the state’s discriminatory ideology that LGBTQ individuals are a “danger” to traditional Russian family values.
A recent poll indicated that roughly one-fifth of Russians want to “eliminate” gay and lesbian individuals from society. In a poll conducted by the Russian LGBT Network — a Russian queer advocacy group — 56 percent of LGBTQ respondents said they had been subjected to psychological abuse, and disturbing reports of state-sanctioned detention and torture of gay and bisexual men in Chechnya, a semi-autonomous Russian region, have surfaced in recent years.
Considering this, it was no surprise that most of my gay friends refused to come on vacation with me to Russia. In our everyday, gay people don’t march around with a gay Pride flag so homophobic Russians would probably never be able to tell which tourists are gay. However, many LGBTQ people will never travel to Russia or any other homophobic country for one logical reason: Fear.
Unfortunately, many exotic locations abroad are dangerous territory for the LGBTQ community to be in. Physical safety isn’t guaranteed in countries like Nigeria, Iran, Brunei and Saudi Arabia where same-sex relationships are punishable by the death penalty. Not to mention the numerous transgender people who’ve been detained and refused entry to similar countries — even when it’s only been a layover! However, an alternative reason why someone may refuse to vacation in a homophobic country is having a conscience.
When you pay for accommodation, nights out and sightseeing tours, your money doesn’t just reach the hotel staff and waiters pockets — you’re also financially supporting that country’s government. Money talks so not giving homophobic countries tourism puts pressure on them. Ethically, why would anybody ever want to support a country through tourism that treats their LGBTQ community like dirt? Homophobia shouldn’t be shrugged off simply as a local “culture.”
Other LGBTQ people firmly embrace the right to go anywhere they choose, and that choosing to go gives them power. Homophobic countries still have closeted LGBTQ folks living there running underground gay spaces and groups. Is turning our back on the wonderful people and beautiful culture of a new place turning our back on their gay community too? There are countries where gay marriage is legal and trans rights are progressive, but abortion laws remain backwards. Do we boycott these countries too? And, how do we collectively define what a homophobic country is? Is legalizing gay marriage a requisite? Gay marriage is still illegal in Thailand when it is one of the most gay and trans-friendly countries in the world.
Increasingly the line of what is “right” and “wrong” erases all grey areas. Morality and activism — particularly when politics is involved — is never straightforward. The biggest surprise about Russia was how my own stereotypes I’d picked up from the media weren’t always true. Saint Petersburg in Russia is far more liberal and gay-friendly compared to rural Russia but the fact still stands that my bisexual friend and I actively chose to go to a homophobic country for pleasure. In an ideal world, anybody of any sexual orientation or gender identity would be able to vacation wherever they want but that’s sadly not reality. In the meantime, the wanderlust LGBTQ community will go on gay cruises that guarantee safe refuge or put civil rights and ideological differences aside to experience the world’s natural wonders and incredible cultures.
Ash Potter is a writer and radio host.
FDA approves injectable PrEP to reduce the risk of sexual HIV infection
Manufactured as Apretude, it will be available to at-risk adults & adolescents who weigh at least 77 pounds & have tested negative for HIV
SILVER SPRING, Md. – The U.S. Food and Drug Administration announced Monday that the agency had approved the first injectable treatment for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV.
Manufactured under the name Apretude, it will be available to at-risk adults and adolescents who weigh at least 77 pounds and have tested negative for HIV immediately beforehand the agency said in a press release.
By granting its approval, the FDA opens up the option for patients to receive the injectable drug instead of a daily HIV prevention oral medication, such as Truvada.
“Today’s approval adds an important tool in the effort to end the HIV epidemic by providing the first option to prevent HIV that does not involve taking a daily pill,” said Debra Birnkrant, M.D., director of the Division of Antivirals in the FDA’s Center for Drug Evaluation and Research. “This injection, given every two months, will be critical to addressing the HIV epidemic in the U.S., including helping high-risk individuals and certain groups where adherence to daily medication has been a major challenge or not a realistic option.”
According to the U.S. Centers for Disease Control and Prevention, notable gains have been made in increasing PrEP use for HIV prevention in the U.S. and preliminary data show that in 2020, about 25% of the 1.2 million people for whom PrEP is recommended were prescribed it, compared to only about 3% in 2015.
However, there remains significant room for improvement. PrEP requires high levels of adherence to be effective and certain high-risk individuals and groups, such as young men who have sex with men, are less likely to adhere to daily medication.
Other interpersonal factors, such as substance use disorders, depression, poverty and efforts to conceal medication also can impact adherence. It is hoped that the availability of a long-acting injectable PrEP option will increase PrEP uptake and adherence in these groups.
The safety and efficacy of Apretude to reduce the risk of acquiring HIV were evaluated in two randomized, double-blind trials that compared Apretude to Truvada, a once daily oral medication for HIV PrEP.
Trial 1 included HIV-uninfected men and transgender women who have sex with men and have high-risk behavior for HIV infection. Trial 2 included uninfected cisgender women at risk of acquiring HIV.
Participants who took Apretude started the trial with cabotegravir (oral, 30 mg tablet) and a placebo daily for up to five weeks, followed by Apretude 600mg injection at months one and two, then every two months thereafter and a daily placebo tablet.
Participants who took Truvada started the trial taking oral Truvada and placebo daily for up to five weeks, followed by oral Truvada daily and placebo intramuscular injection at months one and two and every two months thereafter.
In Trial 2, 3,224 cisgender women received either Apretude or Truvada. The trial measured the rate of HIV infections in participants who took oral cabotegravir and injections of Apretude compared to those who took Truvada orally.
The trial showed participants who took Apretude had 90% less risk of getting infected with HIV when compared to participants who took Truvada.
Apretude includes a boxed warning to not use the drug unless a negative HIV test is confirmed. It must only be prescribed to individuals confirmed to be HIV-negative immediately prior to starting the drug and before each injection to reduce the risk of developing drug resistance.
Drug-resistant HIV variants have been identified in people with undiagnosed HIV when they use Apretude for HIV PrEeP. Individuals who become infected with HIV while receiving Apretude for PrEP must transition to a complete HIV treatment regimen.
The drug labeling also includes warnings and precautions regarding hypersensitivity reactions, hepatotoxicity (liver damage) and depressive disorders.
FDA slow in responding to calls for end to ban on MSM tissue donors
‘Scientific evidence does not support these restrictions’
As of early this week, the U.S. Food and Drug Administration had yet to respond to a Nov. 29 joint letter by 52 members of the U.S. House and U.S. Senate calling on the FDA to end its policy of restricting the donation of human tissues such as corneas, heart valves, skin, and other tissue by men who have sex with men, or MSM.
The letter is addressed to Acting FDA Commissioner Janet Woodcock and Department of Health and Human Services Secretary Xavier Becerra. The FDA is an agency within the HHS.
The letter says the FDA’s restrictions on MSM tissue donation date back to a 1994 U.S. Public Health Service “guidance” related to the possible transmission of HIV, which stated that any man “who has had sex with another man in the preceding five years” should be disqualified from tissue donation.
“We also call your attention to the broad consensus within the medical community indicating that the current scientific evidence does not support these restrictions,” the letter states. “We have welcomed the FDA’s recent steps in the right direction to address its discriminatory MSM blood donation policies and urge you to take similar actions to revise the agency’s tissue donation criteria to align with current science so as not to unfairly stigmatize gay and bisexual men.”
The letter adds, “In fact, a recent study in the medical journal JAMA Ophthalmology estimated that between 1,558 and 3,217 corneal donations are turned away annually from otherwise eligible donors who are disqualified because of their sexual orientation, an unacceptable figure given widespread shortages of transplantable corneas.”
The letter continues, saying, “FDA policy should be derived from the best available science, not historic bias and prejudice. As with blood donation, we believe that any deferral policies should be based on individualized risk assessment rather than a categorical, time-based deferral that perpetuates stigma.”
U.S. Sen. Tammy Baldwin (D-Wisc.), the nation’s only out lesbian U.S. senator, and U.S. Rep. Joe Neguse (D-Colo.) are the two lead signers of the letter. All 52 signers of the letter are Democrats.
Among the others who signed their names to the FDA letter are four of the nine openly gay or lesbian members of the U.S. House. They include Reps. David Cicilline (D-R.I.), Richie Torres (D-N.Y.), Mondaire Jones (D-N.Y.), and Mark Takano (D-Calif.).
Also signing the letter are D.C. Congressional Del. Eleanor Holmes Norton (D-D.C.), and Rep. Jamie Raskin (D-Md.).
In response to a Dec. 21 email inquiry from the Washington Blade, FDA Press Officer Abigail Capobianco sent the Blade a one-sentence statement saying, “The FDA will respond to the letter directly.”
The statement didn’t say to whom the FDA would respond or when it would issue its response.
Judge rules trans teacher’s lawsuit against P.G. County can go to trial
LGBTQ groups stop short of criticizing Sinema for obstructing filibuster reform
Blade contributor nominated for GLAAD Media Award
FreeState Justice outlines 2022 legislative priorities
Mother says teen boy charged with assault in girl’s bathroom at Va. school is straight
Polish House passes bill echoing Russia “gay propaganda” law
The future of lesbian bars
Seeking love and community in Nicaragua
Va. bill would restrict transgender students access to school bathrooms
Leather and lace in your home decor
Sign Up for Blade eBlasts
Opinions6 days ago
Breaking barriers as an out trans ‘Jeopardy’ champion
World2 days ago
Polish House passes bill echoing Russia “gay propaganda” law
World6 days ago
Kenya bill seeks to ban gays from having children via surrogate
Local6 days ago
Anti-LGBTQ Fairfax school board member named to Youngkin administration
Movies6 days ago
‘Potato’ charms with tale of gay Russian immigrant and his mom
Opinions4 days ago
The future of lesbian bars
Local6 days ago
The kink must go on
Books4 days ago
Seeking love and community in Nicaragua